Esperanza M. Algarín

The Novel Pan-PIM Kinase Inhibitor, PIM447, Displays Dual Antimyeloma and Bone-Protective Effects, and Potently Synergizes with Current Standards of Care

Teresa Paíno, Antonio García-Gómez, Lorena González-Méndez et al. · Clinical Cancer Research · 2016 · 54 citations · Full text

Preclinical evaluation of the simultaneous inhibition of MCL-1 and BCL-2 with the combination of S63845 and venetoclax in multiple myeloma

Esperanza M. Algarín, Andrea Díaz-Tejedor, Pedro Mogollón et al. · Haematologica · 2019 · 54 citations · Full text

The kinesin spindle protein inhibitor filanesib enhances the activity of pomalidomide and dexamethasone in multiple myeloma

Susana Hernández-García, Laura San‐Segundo, Lorena González-Méndez et al. · Haematologica · 2017 · 39 citations · Full text

Protein Translation Inhibition is Involved in the Activity of the Pan-PIM Kinase Inhibitor PIM447 in Combination with Pomalidomide-Dexamethasone in Multiple Myeloma

Teresa Paíno, Lorena González-Méndez, Laura San‐Segundo et al. · Cancers · 2020 · 12 citations · Full text

Stroma-Mediated Resistance to S63845 and Venetoclax through MCL-1 and BCL-2 Expression Changes Induced by miR-193b-3p and miR-21-5p Dysregulation in Multiple Myeloma

Esperanza M. Algarín, Dalia Quwaider, Francisco Campos‐Laborie et al. · Cells · 2021 · 11 citations · Full text